Related Experiment Video

Updated: Jun 11, 2025

A Preterm Rat Model for Pain Studies
01:37

A Preterm Rat Model for Pain Studies

Published on: February 9, 2024

332

Emerging evidence of a link between inflammation and the neuropathology of prenatal opioid exposure

Isobel A R Williams1, Kelly J Clemens1

  • 1School of Psychology, University of New South Wales, Sydney, NSW 2052, Australia.

Current Opinion in Neurobiology
|October 4, 2024
PubMed

Insights

Prenatal opioid exposure in infants causes inflammation and immune system dysregulation, leading to negative health outcomes. Understanding these immune changes is key to developing new treatments.

Area of Science:

  • Neuroscience
  • Immunology
  • Public Health

Background:

  • Opioid use is rising, especially among women of reproductive age.
  • This leads to more infants born with prenatal opioid exposure and adverse effects.
  • Inflammation is a consistent feature of prenatal opioid exposure.

Purpose of the Study:

  • To identify immune changes in infants exposed to opioids prenatally.
  • To understand the role of inflammation in opioid-related neuropathology.

Main Methods:

  • Review of studies from the past 5 years.
  • Analysis of human and rodent studies on prenatal opioid exposure.
  • Detection of innate and adaptive immune dysregulation.

Main Results:

  • Prenatal opioid exposure is linked to peripheral and central inflammation.
  • Innate and adaptive immunity are dysregulated in exposed infants.
  • Inflammation likely contributes to neuropathology.

Conclusions:

  • Immune system alterations are a significant consequence of prenatal opioid exposure.
  • Identifying specific immune changes is crucial for therapeutic development.
  • Further research is needed to target inflammation and immune dysregulation.

More Related Videos

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C07:13

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C

Published on: March 25, 2016

18.3K
Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

9.3K

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
547
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
564
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.7K